dengue fever

Director upheaval threatens Brazilian dengue vaccine program, scientists say

FiercePharmaAsia: GSK’s new China head, repercussions from Japan’s Opdivo price cut, Takeda’s €100M dengue vax plant, Sun Pharma and others

Takeda's hefty dengue PhIII displays a vaccine unit with new 'global footprint,' exec says

Sanofi's struggling dengue vaccine could face competition from India/U.S. alliance